**Core Concept**
Acute hepatocellular failure in a patient with cirrhosis of the liver is often precipitated by events that lead to increased intrahepatic resistance, decreased hepatic perfusion, or the release of vasoactive substances. The liver's ability to metabolize and detoxify substances is compromised in cirrhosis, making it more susceptible to further insult.

**Why the Correct Answer is Right**
Upper gastrointestinal bleeding (UGIB) is a common precipitant of acute decompensation in cirrhosis. This is due to the release of vasoactive substances, such as vasopressin and norepinephrine, which are produced in response to bleeding. These substances cause splanchnic vasoconstriction, which increases intrahepatic resistance and reduces hepatic blood flow. Additionally, UGIB can lead to hypovolemia, further compromising hepatic perfusion. The combination of reduced hepatic blood flow and increased intrahepatic resistance can precipitate acute hepatocellular failure in a patient with cirrhosis.

**Why Each Wrong Option is Incorrect**
**Option B:** A large carbohydrate meal is unlikely to precipitate acute hepatocellular failure in cirrhosis, as the liver's ability to metabolize carbohydrates is not significantly impaired in this condition. The liver's metabolic capacity is more likely to be overwhelmed by substances that require more complex metabolism, such as alcohol or certain medications.

**Option C:** Portal vein thrombosis can lead to increased intrahepatic resistance and reduced hepatic perfusion, but it is not a common precipitant of acute decompensation in cirrhosis. This condition is more likely to cause portal hypertension and its associated complications, such as variceal bleeding and ascites.

**Option D:** Intravenous albumin infusion is actually a treatment for hypovolemia and ascites in cirrhosis, rather than a precipitant of acute decompensation. Albumin can help to expand plasma volume and reduce portal pressure, making it a useful adjunct in the management of cirrhosis.

**Clinical Pearl / High-Yield Fact**
In patients with cirrhosis, it is essential to aggressively manage precipitating factors, such as UGIB, to prevent acute decompensation. This may involve the use of vasopressin antagonists, such as terlipressin, to counteract the effects of vasoactive substances released in response to bleeding.

**✓ Correct Answer: A. Upper gastrointestinal bleeding.**